+Search query
-Structure paper
Title | BRAF oncogenic mutants evade autoinhibition through a common mechanism. |
---|---|
Journal, issue, pages | Science, Vol. 388, Issue 6750, Page eadp2742, Year 2025 |
Publish date | May 29, 2025 |
![]() | Hugo Lavoie / Ting Jin / Driss Lajoie / Marion Decossas / Patrick Gendron / Bing Wang / Frantisek Filandr / Malha Sahmi / Chang Hwa Jo / Sandra Weber / Geneviève Arseneault / Sasmita Tripathy / Pierre Beaulieu / Doris A Schuetz / David C Schriemer / Anne Marinier / William J Rice / Pierre Maisonneuve / Marc Therrien / ![]() ![]() ![]() |
PubMed Abstract | Uncontrolled activation of the rat sarcoma (RAS)-extracellular signal-regulated kinase (ERK) pathway drives tumor growth, often because of oncogenic BRAF mutations. BRAF regulation, involving ...Uncontrolled activation of the rat sarcoma (RAS)-extracellular signal-regulated kinase (ERK) pathway drives tumor growth, often because of oncogenic BRAF mutations. BRAF regulation, involving monomeric autoinhibition and activation by dimerization, has been intensely scrutinized, but mechanisms enabling oncogenic mutants to evade regulation remain unclear. By using cryo-electron microscopy, we solved the three-dimensional structures of the three oncogenic BRAF mutant classes, including the common V600E variant. These mutations disrupted wild-type BRAF's autoinhibited state, mediated by interactions between the cysteine-rich domain and kinase domain, thereby shifting the kinase domain into a preactivated conformation. This structural change likely results from helix αC displacement. PLX8394, a BRAF inhibitor that stabilizes helix αC in an inactive conformation, restored the autoinhibited conformation of oncogenic BRAF, explaining the properties of this class of compounds. |
![]() | ![]() ![]() |
Methods | EM (single particle) |
Resolution | 3.06 - 5.86 Å |
Structure data | EMDB-43673, PDB-8vyo: EMDB-43674, PDB-8vyp: EMDB-43675, PDB-8vyq: EMDB-43676, PDB-8vyr: EMDB-43677, PDB-8vys: EMDB-43678, PDB-8vyu: EMDB-43679, PDB-8vyv: EMDB-43680, PDB-8vyw: |
Chemicals | ![]() ChemComp-ZN: ![]() ChemComp-AGS: ![]() PDB-1aen: |
Source |
|
![]() | TRANSFERASE/INHIBITOR / BRAF Kinase Monomer / TRANSFERASE-INHIBITOR complex / BRAF Kinase Oncogenic Mutant Monomer / BRAF Kinase Monomer Mutant Inhibitor / BRAF Kinase Monomer Inhibitor |